Biogen (BIIB) PT Raised to $435 at JPMorgan
Get Alerts BIIB Hot Sheet
Price: $190.52 --0%
Rating Summary:
29 Buy, 13 Hold, 0 Sell
Rating Trend: Down
Today's Overall Ratings:
Up: 9 | Down: 16 | New: 16
Rating Summary:
29 Buy, 13 Hold, 0 Sell
Rating Trend: Down
Today's Overall Ratings:
Up: 9 | Down: 16 | New: 16
Join SI Premium – FREE
JPMorgan analyst Cory Kasimov raised the price target on Biogen (NASDAQ: BIIB) to $435.00 (from $269.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Biogen (BIIB) PT Lowered to $270 at Oppenheimer
- Biogen (BIIB) PT Lowered to $214 at UBS
- Integra Resources Corp (ITR:CN) (IRRZF) PT Lowered to Cdn$4 at Stifel Canada
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!